Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection.
about
Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietinX-Linked agammaglobulinemia patients are not infected with Epstein-Barr virus: implications for the biology of the virus.Dual stimulation of Epstein-Barr Virus (EBV)-specific CD4+- and CD8+-T-cell responses by a chimeric antigen construct: potential therapeutic vaccine for EBV-positive nasopharyngeal carcinomaThe lymph node in HIV pathogenesisReversal in fatigued athletes of a defect in interferon gamma secretion after administration of Lactobacillus acidophilusOn the dynamics of acute EBV infection and the pathogenesis of infectious mononucleosisViral immune evasion due to persistence of activated T cells without effector functionPhase I trial of a CD8+ T-cell peptide epitope-based vaccine for infectious mononucleosisAn N-acetylated natural ligand of human histocompatibility leukocyte antigen (HLA)-B39. Classical major histocompatibility complex class I proteins bind peptides with a blocked NH(2) terminus in vivoSimultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti- CD3 mAb T-cell expansion and "RecycleSpot"Epstein-barr virus sequence variation-biology and diseaseEBV promotes human CD8 NKT cell developmentKIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A * 11 while diminishing avidity for HLA-CIn vitro cytokine production and growth inhibition of lymphoblastoid cell lines by CD4+ T cells from Epstein-Barr virus (EBV) seropositive donorsAn efficient strategy to induce and maintain in vitro human T cells specific for autologous non-small cell lung carcinomaType 2 cytokines predominate in the human CD4(+) T-lymphocyte response to Epstein-Barr virus nuclear antigen 1.Prevalence of periodontitis in individuals with human leukocyte antigens (HLA) A9, B15, A2, and B5.Human CD4(+) T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1.Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell responseFunctional inactivation of EBV-specific T-lymphocytes in nasopharyngeal carcinoma: implications for tumor immunotherapyIntron retention may regulate expression of Epstein-Barr virus nuclear antigen 3 family genesHuman immunodeficiency virus (HIV)-specific gamma interferon secretion directed against all expressed HIV genes: relationship to rate of CD4 decline.Transfer of EBV-specific CTL to prevent EBV lymphoma post bone marrow transplant.HIV-1-specific IFN-gamma/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells.Dissecting the host response to a gamma-herpesvirus.Identification of a cytotoxic T-lymphocyte response to the novel BARF0 protein of Epstein-Barr virus: a critical role for antigen expressionT-cell vaccination alters the course of murine herpesvirus 68 infection and the establishment of viral latency in mice.Dendritic cells transduced with an adenovirus vector encoding Epstein-Barr virus latent membrane protein 2B: a new modality for vaccination.CD4+ T-cell effectors inhibit Epstein-Barr virus-induced B-cell proliferation.Linkage between STAT regulation and Epstein-Barr virus gene expression in tumors.Epstein-Barr virus infection of renal proximal tubule cells: possible role in chronic interstitial nephritisT-cell memory: lessons from Epstein-Barr virus infection in manDetection of Epstein-Barr virus genomes in peripheral blood B cells from solid-organ transplant recipients by fluorescence in situ hybridization.Microbial Infection and Rheumatoid Arthritis.MYC overexpression imposes a nonimmunogenic phenotype on Epstein-Barr virus-infected B cells.Soluble rhesus lymphocryptovirus gp350 protects against infection and reduces viral loads in animals that become infected with virus after challengeActivation of NF-κB via endosomal Toll-like receptor 7 (TLR7) or TLR9 suppresses murine herpesvirus 68 reactivation.Kinetic analysis of the specific host response to a murine gammaherpesvirusMemory CD8 T-cell differentiation during viral infection.HLA-A*02:07 is a protective allele for EBV negative and a susceptibility allele for EBV positive classical Hodgkin lymphoma in China
P2860
Q24320304-41C66565-F5A7-4703-B519-6C65C9096B50Q24517035-3BF7E814-2776-4277-8568-276DF4053328Q24610485-598B07EE-95AB-4BCE-B539-7F3280286F0EQ24644783-0FD7629B-909F-442E-BC26-B26CAAFDB576Q24645007-10DE0BFD-51C9-4080-A883-916EF71E5B57Q24645207-52C66EC1-A002-4C41-8CEB-1FB534ADC933Q24646943-13CCE26F-A9A4-4A32-B268-9BA2C522EF36Q24657081-512D4E1C-4766-4EF1-BA3F-BC3418D35654Q24676272-6A8F8E3C-7838-402B-843E-12884B25BD64Q24814428-DB4E194D-8C72-4681-9275-9E12386A6A8BQ27003183-98329BD1-6E81-486A-9281-75A54B49861CQ27314724-BBCAA602-E899-4727-AACE-5ED77BB9AA84Q27657994-68797792-6DCE-4981-BC2F-41FB3EE15D0CQ28362603-1C792488-6F9B-476A-8DB6-210E48771294Q28749871-9915038B-16B9-44D3-B388-FC366A2F1B9FQ30305830-4F543A56-77F4-40B8-8EA3-A82B41186DC1Q30316249-BC1E73AD-BFFF-43BB-BC3D-211A532EE258Q30442797-AD280E4B-F09C-4415-86CC-B0F6C80FC7FEQ30442835-482ED979-836C-4AD6-9ACB-F47FFB848E8CQ33305203-A03A961C-3778-4A79-B373-B18C2AE56ACFQ33640843-D494272F-504F-4885-A8B5-42661101226BQ33724256-8D27E14B-0FAE-485F-905F-8752885E8154Q33762569-039D2366-49F3-40FE-85F8-F7473B9F6EE1Q33772204-CC5CBC72-4C75-4B1E-8BB7-F247F9F33EAAQ33772250-16E761D3-DF30-4AAA-82A9-4F30090E5C44Q33783532-F84A1E62-9FC2-43F5-BAB5-E3A3B7CB949FQ33824612-571F1341-9892-46C6-A508-EFFDBE050736Q33825567-D961C410-531C-454F-9142-8C670254E9A9Q33851257-CE823244-DA84-4FB2-AFA3-3EB11C7D5788Q33866046-E79FA4CD-D331-47A7-A58D-8565CB57EF7EQ33903084-CAA91109-6AE7-4C0A-86F2-C06243129F3CQ33905235-4C206CCA-32F5-4B10-B077-4882ACD2E3BBQ33962280-8DB6B176-4BAB-4F21-B32D-280721F3FBCFQ34040402-B5EC3B44-3CBE-4645-866E-ED91160A7247Q34048911-42D2FF45-1FAF-43CD-9DF8-81BBF78C71B1Q34058118-B69ED643-2294-4AFB-9155-46BDC633F597Q34059398-83063D76-1C73-43C7-8305-A170E688C522Q34068985-AD26493F-5681-4987-8027-659DCEF4F8EDQ34152220-0CF00D4D-F300-48D1-AF1A-E5814338B9B1Q34166497-CA65201F-E394-487D-A3C3-3C2215B034B2
P2860
Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection.
@en
type
label
Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection.
@en
prefLabel
Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection.
@en
P1476
Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection.
@en
P2093
P304
P356
10.1146/ANNUREV.IMMUNOL.15.1.405
P577
1997-01-01T00:00:00Z